ORION PHARMA A/S: Financial statements 2015
CVR: 20601116
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 272,966,662 and a net result of DKK 44,821,782 compared with DKK 24,675,624 the year before. That is an increase of 63.6% compared with the year before. The profit margin was 16.4%. Equity in the 2015 report amounted to DKK 66,614,602. The solvency ratio was 54.4%. The company had 28 employees in the financial year.
- Revenue
- DKK 272,966,662
- Gross Profit
- DKK 85,296,771
- Profit/Loss
- DKK 44,821,782
- Equity
- DKK 66,614,602
- Total Assets
- DKK 122,350,307
- Employees
- 28
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 273 mio. | 85.3 mio. | 44.8 mio. | 66.6 mio. | 28 |
| 2014 | 166.9 mio. | 59.3 mio. | 24.7 mio. | 46.8 mio. | 31 |
| 2013 | 164.8 mio. | 64.9 mio. | 25.6 mio. | 39.1 mio. | 33 |
Official annual report
How creditworthy is ORION PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 1, 2015, Jesper Otto Qvist-Pedersen is registered as adm. dir. of ORION PHARMA A/S.
As of October 31, 2015, Kaisa Tarkkanen has stepped down as adm. dir. of ORION PHARMA A/S.
ORION PHARMA A/S has published its annual report for 2014. Revenue came to DKK 166,850,619, and the net result was DKK 24,675,624.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.